W. Schmidt — Endo Lab

2020

Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics ·doi:10.1007/s13311-020-00935-1

paratext 2019

(no title)

·doi:10.15574/pp.2019.80.

НАЦІОНАЛЬНА АКАДЕМІЯ МЕДИЧНИХ НАУК УКРАЇНИ ДЕРЖАВНА УСТАНОВА «ІНСТИТУТ ПЕДІАТРІЇ, АКУШЕРСТВА І ГІНЕКОЛОГІЇІМЕНІ АКАДЕМІКА О.М

article 2008

Original research article Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies ☆,☆☆

Background: Attempts to improve the tolerability of combined oral contraceptives (COCs) have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this has proved unsatisfactory, specifically in terms of cycle…

article 2008

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies

·doi:10.1016/j.contraception.2008.05.004

BackgroundAttempts to improve the tolerability of combined oral contraceptives (COCs) have included the substitution of ethinylestradiol (EE) with 17beta-estradiol (E2). However, this has proved unsatisfactory, specifically in terms of cycl…

article 2007

A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

·doi:10.1080/13625180701441030

OBJECTIVES: To evaluate the impact of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate (1EV) and 2 mg dienogest (2DNG) on metabolism. METHODS: In a randomized double-blind…

article 2005

Relationship Between Etiology of Sterility of Patients Undergoing Controlled Ovarian Hyperstimulation (COH) and Serum, Follicular Fluid Concentration of Leukaemia Inhibitory Factor (LIF), Vascular Endothelial Growth Factor (VEGF), Nitic Oxide (NO) and Their Influence on ICSI Outcome

·doi:10.1016/j.fertnstert.2005.07.270

article 2003

Fibroblast Growth Factor (FGF), Intracellular Adhesion Molecule (sICAM‐1) Level in Serum and Follicular Fluid of Infertile Women with Polycystic Ovarian Syndrome, Endometriosis and Tubal Damage, and their Effect on ICSI Outcome

American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1034/j.1600-0897.2003.00056.x

PROBLEM: The objective of this study was to determine the concentration of fibroblast growth factor (FGF) and soluble intracellular adhesions molecule (sICAM-1) in serum and follicular fluid (FF) of polycystic ovary (PCO), endometriosis and…

article 1999

Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer

European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/s0301-2115(98)00166-3

The fourth case of heterologous mesodermal tumour of the uterine corpus, that developed, years following tamoxifen therapy for breast cancer in a postmenopausal woman with no previous pelvic irradiation, is presented with coincidental endom…

book-chapter 1996

The Role of Doppler-Ultrasonography in Reproductive Medicine

·doi:10.1007/978-3-642-60961-9_29

other 1985

[Diagnosis of benign and malignant ovarian tumors]

Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1036487

The present paper reports on the value of gynecological-clinical examinations and preoperative ultrasonography in the diagnosis of benign and malignant ovarian tumors. Out of a group of 42 patients, in all of whom "ovarian cyst" had only be…

article 1935

Regeneration of vaginal epithelium as affected by follicular hormone and in vitamin A deficiency.